SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Graham Dellaire who wrote (736)9/4/2000 2:22:12 AM
From: Larry G.  Read Replies (1) of 792
 
Hi Graham.

I am glad to hear you are back. It has been pretty lonely with MBI. Every one had abandoned me. I was kicking myself for not selling when it was $12 and above. At least some of my shares. I did not but when it fell to $5, I started buying again. I had a lot of shares before but I increased my position by 12%.

I would be happy to see $14.5 which would give me a very good profit but I think it could be higher. Think of where we will be in one year.

1. Phase 3 for MBI 226 could be finished.

2. We could be preparing for New Drug Application for MBI 226.

3. We could have finished phase 2 and be preparing for or into phase 3 of acne drug (MBI 594).

4. We could be finished phase 2 and be preparing for or into phase 3 of staphylcoccus aureus infections (MBI 853).

5. We could have another drug in clinical trials.

There could be some other surprises we have not heard about like deal with UCLA. We did not get any price move with that news announcement but I think it shows the quality of company MBI is or UCLA would not do business with Micrologix.

I am hoping for more than $14.50.

Good to hear from you.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext